Day One Biopharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2023 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Day One Biopharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2023 to Q4 2024.
  • Day One Biopharmaceuticals, Inc. Return On Equity for the quarter ending December 31, 2024 was -23 %, a 55.5% increase year-over-year.
  • Day One Biopharmaceuticals, Inc. annual Return On Equity for 2024 was -23 %, a 55.5% increase from 2023.
  • Day One Biopharmaceuticals, Inc. annual Return On Equity for 2023 was -51.7 %, a 22.2% decline from 2022.
  • Day One Biopharmaceuticals, Inc. annual Return On Equity for 2022 was -42.3 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -23 +28.7 +55.5% Oct 1, 2024 Dec 31, 2024
Q3 2024 -22.4 Jul 1, 2024 Sep 30, 2024
Q2 2024 -50 Apr 1, 2024 Jun 30, 2024
Q1 2024 -57.3 Jan 1, 2024 Mar 31, 2024
Q4 2023 -51.7 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.